GMP , Claim And Label Warning Follows Firm's Ephedra Recall

摘要

FDA Office of Regulatory Affairs' warning letter to MusclMasster lists 12 separate violations of supplement GMP regulations. Puerto Rico firm is latest supplement own-labeler to receive GMP warnings. A Colorado herbal supplement firm received an FDA warning letter about extensive good manufacturing practices problems and violative claims three months after recalling an ephedra-containing product and after questioning why it should document production yields.